Exagen Inc (XGN)

Überblick Nachrichten Preisverlauf Optionskette Financials Forum Prognose

Finanzdaten der Exagen Inc-Aktie (XGN)

*Alle Zahlen in Millionen

Enddatum des Zeitraums	2025-12-31	2025-09-30	2025-06-30	2025-03-31	2024-12-31
Periodenlänge	3 Monate	3 Monate	3 Monate	3 Monate	3 Monate
Revenues	3.55% 16.63	17.24	17.20	15.50	13.65
Cost Of Revenue	3.57% 7.425	7.169	6.807	6.375	5.178
Gross Profit	8.63% 9.206	10.07	10.39	9.123	8.477
Operating Expenses	7.64% 14.18	13.18	13.03	12.49	11.86
Benefits Costs and Expenses	7.64% 14.18	13.18	13.03	12.49	-5.491
Costs And Expenses	7.64% 14.18	13.18	13.03	12.49	-5.491
Operating Income/Loss	60.48% -4.975	-3.10	-2.63	-3.365	-3.383
Income/Loss From Continuing Operations Before Tax	39.79% 2.45	4.069	-4.439	-3.752	19.15
Income Tax Expense/Benefit	1,200% 0.013	0.001	0.037	-	-
Income/Loss From Continuing Operations After Tax	34.06% -4.673	-7.087	-4.439	-3.752	-3.761
Net Income/Loss	34.06% -4.673	-7.087	-4.439	-3.752	-3.761
Preferred Stock Dividends And Other Adjustments	-	-	-	-	-
Attributable To Noncontrolling Interest	-	-	-	-	-
Basic Average Shares	97.04% 0.6799	22.94	21.09	18.56	0.0755
Diluted Average Shares	97.04% 0.6799	22.94	21.09	18.56	0.0755
Basic Earnings Per Share	35.48% -0.20	-0.31	-0.21	-0.20	-0.20
Diluted Earnings Per Share	35.48% -0.20	-0.31	-0.21	-0.20	-0.20
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic	-	-	-	-	-

$264.90

0.76%

DGX

$199.75

0.67%

MTD

$1,173.79

0.50%

NTRA

$188.84

0.09%

IQV

$164.68

1.07%

WAT

$286.49

1.12%